Publication Name	World Journal of Clinical Cases
Manuscript ID	82678
Country	China

Received	2022-12-27 03:41
Peer-Review Started	2022-12-27 03:42
To Make the First Decision
Return for Revision	2023-01-20 00:46
Revised	2023-02-02 10:34
Second Decision	2023-03-22 02:59
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2023-03-22 07:53
Articles in Press	2023-03-22 07:53
Publication Fee Transferred
Edit the Manuscript by Language Editor	2023-03-16 02:49
Typeset the Manuscript	2023-03-28 07:35
Publish the Manuscript Online	2023-04-06 10:35

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Dermatology
Manuscript Type	Case Report
Article Title	Successful treatment of lichen amyloidosis coexisting with atopic dermatitis by dupilumab: Four case reports
Manuscript Source	Unsolicited Manuscript
All Author List	Qing Zhu, Bing-Quan Gao, Jin-Fang Zhang, Li-Ping Shi and Guo-Qiang Zhang
ORCID	Author(s) ORCID Number Qing Zhu http://orcid.org/0000-0002-7075-7696 Guo-Qiang Zhang http://orcid.org/0000-0002-4132-1690
Funding Agency and Grant Number
Corresponding Author	Guo-Qiang Zhang, MD, Director, Director, Professor, Department of Dermatology, The First Hospital of Hebei Medical University, No. 89 Donggang Road, Shijiazhuang 050031, Hebei Province, China. zlx090702@163.com
Key Words	Lichen amyloidosis; Atopic dermatitis; Dupilumab; Biologics; Interleukin-31; Case report
Core Tip	Lichen amyloidosis (LA) is a chronic, severely pruritic skin disease, which is the most common subtype of primary cutaneous amyloidosis characterized by deposition of amyloid protein on the skin without visceral involvement. The treatment of LA has been considered difficult, with high relapse rates. In this article, we present four cases of LA associated with atopic dermatitis (AD) treated with dupilumab who achieved remarkable results. Our observations suggested that dupilumab may shed light on the systematic treatment of refractory LA patients with AD.
Publish Date	2023-04-06 10:35
Citation	Zhu Q, Gao BQ, Zhang JF, Shi LP, Zhang GQ. Successful treatment of lichen amyloidosis coexisting with atopic dermatitis by dupilumab: Four case report. World J Clin Cases 2023; 11(11): 2549-2558
URL	https://www.wjgnet.com/2307-8960/full/v11/i11/2549.htm
DOI	https://dx.doi.org/10.12998/wjcc.v11.i11.2549

Full Article (PDF)	WJCC-11-2549.pdf
Full Article (Word)	WJCC-11-2549.docx
Manuscript File	82678_Auto_Edited-JPY-Wang TQ-JLW.docx
Answering Reviewers	82678-Answering reviewers.pdf
Audio Core Tip	82678-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	82678-Conflict-of-interest statement.pdf
Copyright License Agreement	82678-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	82678-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	82678-Language certificate.pdf
Peer-review Report	82678-Peer-review(s).pdf
Scientific Misconduct Check	82678-Bing-Yan JP-2.png
Scientific Editor Work List	82678-Scientific editor work list.pdf
CrossCheck Report	82678-CrossCheck report.pdf